Evidence map›Paper›PMID 22290423›Full record

ArticleCell research2012

Preferential CTL targeting of Gag is associated with relative viral control in long-term surviving HIV-1 infected former plasma donors from China.

Mingming Jia, Kunxue Hong, Jianping Chen, Yuhua Ruan, Zhe Wang, Bing Su, Guoliang Ren, Xiaoqing Zhang, Zhen Liu, Quanbi Zhao and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell research, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. CD8Heliyon · 2024
    Article
  4. Control of HIV-1 Replication by CD8Journal of virology · 2022
    Article
  5. Article
  6. Adenovirus-vectored vaccine containing multidimensionally conserved parts of the HIV proteome is immunogenic in rhesus macaques.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Mingming JiaState Key Laboratory for Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Kunxue Hong
Jianping Chen
Yuhua Ruan
Zhe Wang
Bing Su
Guoliang Ren
Xiaoqing Zhang
Zhen Liu
Quanbi Zhao
Dan Li
Hong Peng
Marcus Altfeld
Bruce D Walker
Xu G Yu
Yiming Shao
Chinese Center For Disease Control and Prevention · CNRagon Institute of MGH, MIT and Harvard · USAnhui Provincial Center for Disease Control and Prevention · CNHenan Provincial Center for Disease Control and Prevention · CN

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
HLA TYPING AND EPITOPE MAPPING RELATIVE TO HIV VACCINE DESIGN-266030024N01AI030024 · NIAID · THE MASSACHUSETTS GENERAL HOSP · 2003 to 2005
–
NIAID NIH HHS N01 AI030024NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

It is generally believed that CD8(+) cytotoxic T lymphocytes (CTLs) play a critical role in limiting the replication of human immunodeficiency virus type 1 (HIV-1) and in determining the outcome of the infection, and this effect may partly depend on which HIV product is preferentially targeted. To address the correlation between HIV-1-specific CTL responses and virus replication in a cohort of former plasma donors (FPDs), 143 antiretroviral therapy naive FPDs infected with HIV-1 clade B' strains were assessed for HIV-1-specific CTL responses with an IFN-γ Elispot assay at single peptide level by using overlapping peptides (OLPs) covering the whole consensus clade B proteome. By using a Spearman's rank correlation analysis, we found that the proportion of Gag-specific CTL responses among the total virus-specific CTL activity was inversely correlated with viral loads while being positively correlated to CD4 counts, as opposed to Pol- and Env-specific responses that were associated with increased viral loads and decreased CD4 counts. In addition, Vpr-specifc CTL responses showed a similar protective effect with Gag responses, but with a much lower frequency of recognition. Significantly, we also observed an association between HLA-A*30/B*13/Cw*06 haplotype and lower viral loads that was probably due to restricted Gag-specific CTL responses. Thus, our data demonstrate the prominent role of Gag-specific CTL responses in disease control. The advantage of HLA-A*30/B*13/Cw*06 haplotype in viral control may be associated with the contribution of Gag-specific CTL responses in the studied individuals.

Indexed as

AdultAgedAmino Acid SequenceAnti-HIV AgentsBlood DonorsCD4 Lymphocyte CountChinaCohort StudiesEnzyme-Linked Immunospot AssayFemalegag Gene Products, Human Immunodeficiency VirusHaplotypesHIV-1HIV InfectionsHLA-A AntigensHLA-B13 AntigenAnti-HIV Agentsgag Gene Products, Human Immunodeficiency VirusHLA-A*30 antigenHLA-A AntigensHLA-B*13:14 antigenHLA-B13 AntigenHLA-C*06 antigenHLA-C AntigensInterferon-gammaPeptides

Identifiers

PMID22290423
PMCPMC3343654
OpenAlexW2035091484

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.